Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RILONACEPT vs RILPIVIRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RILONACEPT vs RILPIVIRINE: Safety Overview

Metric RILONACEPT RILPIVIRINE
Total FAERS Reports 843 7,049
Deaths Reported 14 196
Death Rate 1.7% 2.8%
Hospitalizations 65 593
Average Patient Age 51.9 yrs 45.8 yrs
% Female Patients 68.2% 29.5%
FDA Approval Date N/A Jan 29, 2026
Manufacturer Kiniksa Pharmaceuticals (UK), Ltd. Janssen Products, LP
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription